Press Releases
10.29.2014 – Mystic Pharmaceuticals Introduces ArrowFish™ Nasal Vaccine and Drug Delivery System
07.30.2014 – Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology
07.14.2014 – Mystic Pharmaceuticals Unveils The Next Generation Of Patient-Centric Sublingual Drug Delivery Devices
04.08.2014 – Mystic Pharmaceuticals Receives U.S. Patent for Human-Centric Unit Dose Drug Packaging and Delivery Technology
03.19.2014 – Mystic Pharmaceuticals Appoints Gerald D. Cagle Ph.D. and Grady Rylander M.D. to Scientific Advisory Board
03.07.2014 – Mystic Pharmaceuticals to Present at 6th Ocular Diseases & Drug Discovery Conference
10.01.2013 – Mystic Pharmaceuticals Receives Notices Of Allowance From Japan and China on Drug Delivery Platform Technologies
09.17.2013 – Mystic Pharmaceuticals Receives Multiple US Patent Office Notices Of Allowance on Drug Delivery Platform Technologies
04.04.2013 – Mystic Pharmaceuticals to Present at the 2013 International Nasal znd Buccal Drug Delivery Conference
03.07.2013 – Mystic Pharmaceuticals to Present at 5th Ocular Diseases & Drug Development Conference
02.08.2013 – Mystic Pharmaceuticals Receives U.S. Patent for Intranasal Delivery Technology For Pharmaceuticals and Biologics
09.20.2012 – Mystic Pharmaceuticals to Present at the 2nd Annual Partnerships In Drug Delivery Conference In Boston
09.12.2012 – Mystic Pharmaceuticals Receives U.S. Patent for Manufacturing Innovative Unit Dose Packaging for Drugs and Biologics
04.11.2012 – Mystic Pharmaceuticals to Present at the International Nasal and Buccal Drug Delivery Conference.
06.13.2011 – Mystic Pharmaceuticals Receives U.S. Patent for Novel Packaging Technology for Drugs and Biologics
11.08.2010 – Mystic Pharmaceuticals Receives Qualifying Therapeutic Discovery Grant For Drug Delivery Technology
05.05.2010 – Mystic Pharmaceuticals Receives U.S. Patent For Needle-Free Vaccine and Drug Delivery Technology
10.08.2009 – MacuCLEAR and Mystic Successfully Complete Phase Ib Clinical Trial for Macular Degeneration
01.13.2009 – MacuCLEAR and Mystic Pharmaceuticals Agree To Collaborate on Macular Degeneration Phase I/II Clinical Trial
09.15.2008 – Mystic Pharmaceuticals CEO To Present At HHS BARDA Public Health Emergency Medical Countermeasures Workshop
07.09.2008 – Mystic CEO Timothy Sullivan Named To Top One Hundred Notable People In Medical Device Industry
05.14.2008 - Mystic Pharmaceuticals Expands Management, Engineering and Scientific Team with Key Hires
01.07.2008 – Mystic Pharmaceuticals CEO Presents At ONEMEDPLACE Finance Forum
02.14.2007 – Mystic Pharmaceuticals Expands Texas Clinical Manufacturing R&D Facility